Integrated Diagnostics has launched InDi Imaging, an operating division designed to create a new generation of PET imaging probes using the company's protein-catalyzed capture (PCC) agent technology.
PCCs, initially developed for in vitro molecular diagnostics, will be developed as in vivo diagnostic imaging probes that mimic the properties of antibodies and biologics in PET molecular imaging, the firm said.
The company has appointed Norman Hardman, PhD, as president of InDi Imaging. Hardman is an honorary professor of medical sciences at the University of Aberdeen in Scotland and currently serves as vice president of the Aberdeen University Development Trust.
Michael Phelps, PhD, chairman of the University of California, Los Angeles' department of molecular and medical pharmacology, has been named as an advisor to InDi Imaging.
